![](/img/cover-not-exists.png)
A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit
Laterre, Pierre-François, Sánchez-GarcÃa, Miguel, van der Poll, Tom, de la Rosa, Olga, Cadogan, Kathy-Ann, Lombardo, Eleuterio, François, BrunoVolume:
20
Journal:
BMC Pulmonary Medicine
DOI:
10.1186/s12890-020-01324-2
Date:
December, 2020
File:
PDF, 1.45 MB
2020